Patients with Graves disease who taper methimazole to a maintenance dose of 1.25 mg/day before discontinuing the drug experience improved remission rates compared to those on higher doses.

Mycenax Biotech Inc. (TWO:4726), a leading biologics CDMO based in Taiwan, today announced strategic alliance with ...

The construction adhesives market is ripe with opportunities due to growing demands for faster, sustainable construction solutions and innovations in adhesive technology. Emerging markets, modular ...

VANCOUVER, BC / ACCESS Newswire / September 15, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce the successful completion of ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Bram Baert, global head of Regulatory Affairs at Lonza CHI, gives his perspective on the impact of the EC’s decision on the ...

GAL-101 was well tolerated; excellent safety and pharmacokinetic profile strongly support oral administrationGAL-101 effectively crosses the blood-brain barrier, supporting further development in ...

Musawa indicated they would not hesitate to take these Acts back to the National Assembly for further revision if necessary ...

Formulation development strategies are influenced by problem-solving, digital tools, and geopolitical changes, highlighting ...

As a step towards formulation of a unified development and building code, a stakeholder consultation workshop was conducted on Tuesday by the Hyderabad Metropolitan Development Authority in ...